Transfusion in patients with massive blood loss: evidence when, for whom and what products are best

Transfusion in patients with massive blood loss: evidence when, for whom and what products are best

Bibliographic Details
Main Author:	Jaap Jan Zwaginga
Format:	Article
Language:	English
Published:	Wiley 2018-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/HS9.0000000000000096

Similar Items

Massive blood transfusion: A case report of transfusion of 70 units of blood and blood products in 24 hours
by: Kompal Jain, et al.
Published: (2018-01-01)

Vaccination strategies and policies: What can be done by whom, when and where?
by: Samantha Vanderslott
Published: (2022-04-01)

Vaccination strategies and policies: What can be done by whom, when and where?
by: Samantha Vanderslott
Published: (2022-04-01)

PSA screening - for whom and when?
by: Peter Albers
Published: (2019-01-01)

Forest for whom and for what?/
by: 257269 Clawson, Marion
Published: (1975)

Cellphones. What for? on whom?
by: Andrea Mubi Brighenti
Published: (2009-09-01)

Determinants of mortality in trauma patients following massive blood transfusion
by: Rangarajan Kanchana, et al.
Published: (2011-01-01)

PHYSIOLOGIC TRANSFUSION TRIGGERS AND MASSIVE TRANSFUSION
by: Tánczos Krisztián, et al.
Published: (2013-01-01)

Physiologic transfusion triggers and massive transfusion
by: Tánczos Krisztian, et al.
Published: (2013-03-01)

Best research--for what? Best health--for whom? A critical exploration of primary care research using discourse analysis.
by: Shaw, S, et al.
Published: (2008)

Lifestyle support preferences of patients with cardiovascular diseases: What lifestyle support might work best for whom?
by: Talia R. Cohen Rodrigues, et al.
Published: (2022-12-01)

VARICOCELE FOR ADOLESCENT – WHOM AND WHEN TO OPERATE
by: V. V. Sizonov, et al.
Published: (2014-03-01)

Freeze-all, for whom, when, and how
by: Paula Celada, et al.
Published: (2020-04-01)

Free trade: why, when and for whom?
by: D. NAYYAR
Published: (2013-10-01)

Giving What to Whom? Thoughts on Feminist Knowledge Production
by: Jade S. Sasser
Published: (2014-07-01)

Six dimensions of research trial acceptability: how much, what, when, in what circumstances, to whom and why?
by: Gooding, K, et al.
Published: (2018)

Massive Blood Transfusions and Outcomes in Trauma Patients; An Intention to Treat Analysis
by: Steven Liu, et al.
Published: (2018-07-01)

Impact of Transfused Citrate on Pathophysiology in Massive Transfusion
by: Jacob B. Schriner, MD, et al.
Published: (2023-06-01)

Traumatic coagulopathy and massive transfusion: improving outcomes and saving blood
by: Karim Brohi, et al.
Published: (2017-11-01)

Effects of a hospital-wide introduction of a massive transfusion protocol on blood product ratio and blood product waste
by: Kirsten Balvers, et al.
Published: (2015-01-01)

When and for Whom Does Growth Becomes Jobless?
by: Mindaugas Butkus, et al.
Published: (2024-01-01)

Radiotherapy in Pancreatic Cancer: To Whom, When, and How?
by: Michał Falco, et al.
Published: (2023-06-01)

DISSOLVING KIDNEY STONES: FOR WHOM? WHEN? HOW?
by: V. V. DUTOV
Published: (2016-12-01)

No transfusion is the best transfusion: a rare case
by: Dibyajyoti Sahoo, et al.
Published: (2017-04-01)

CT-severity score in COVID-19 patients: for whom is it applicable best?
by: Alireza Almasi Nokiani, et al.
Published: (2022-01-01)

The what, the whom, and the hows of survey research /
by: 281320 Sherblom, John C., et al.

School and teachers: for whom, why and what for?
by: Fernanda Cristina Carvalho de Mello, et al.
Published: (2017-03-01)

Science and technology: socialising what for whom?
by: Sally Wyatt
Published: (2009-09-01)

What works best for whom? Cognitive Behavior Therapy and Mindfulness-Based Cognitive Therapy for depressive symptoms in patients with diabetes.
by: K Annika Tovote, et al.
Published: (2017-01-01)

Massive Transfusion for Postpartum Hemorrhage
by: Danielle Hart, et al.
Published: (2013-12-01)

CURRENT PRACTICE OF INTRODUCTION OF COMPLEMENTARY FEEDING PRODUCTS: TO WHOM? WHEN? HOW MUCH?
by: Y. A. Dmitrieva, et al.
Published: (2017-12-01)

Synthesis of the Evidence on What Works for Whom in Telemental Health: Rapid Realist Review
by: Merle Schlief, et al.
Published: (2022-09-01)

Dexamethasone in Patients Hospitalized with COVID-19: Whether, When and to Whom
by: Luigino Calzetta, et al.
Published: (2021-04-01)

For whom and by whom is glaciology?
by: Alexander A. Robel, et al.

Diagnosing early cognitive decline - when, how and for whom?
by: Allan, C, et al.
Published: (2016)

Equivalent/generic drugs use. To whom? When? How?
by: Andrea Fontanella
Published: (2014-05-01)

Capsule Endoscopy in Inflammatory Bowel Disease: When? To Whom?
by: Soo-Young Na, et al.
Published: (2021-11-01)

Active surveillance for prostate cancer: to whom, when and how
by: M. S. Taratkin, et al.
Published: (2019-09-01)

Fluoroquinolones in ambulatory surgical practice: whom, when, how?
by: A. V. Golub, et al.
Published: (2016-06-01)

Severe Asthma and Biological Therapy: When, Which, and for Whom
by: Paola Rogliani, et al.
Published: (2019-12-01)